MedTrace Logo

Trial on Three Eating Disorders Group Treatment

NCT05140109 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-12-09

No results posted yet for this study

Summary

This trial aims at comparing three group treatments designed for eating disorders: a Cognitive-dissonance, a Mindfulness and a Person-centered based programs. Women with eating disorders will be recruited and randomized to one of the three programs. Participants will complete a pretest, a posttest, a 3-months follow-up and a 1-year follow-up. This trial aims to compare the programs to analyze the specific dimensions upon which each program acts. The investigators therefore made hypotheses according to the programs' theory: participants in the Cognitive-dissonance based program should experience a greater decrease in eating disorders symptoms, thin-ideal internalization and body dissatisfaction and a greater improvement in quality of life than other participants. Participants in the Mindfulness-based program should show a greater improvement in negative affect and in equanimity than other participants. Participants in the Person-Centered based program should report a greater increase in congruence than other participants.

Conditions

Interventions

OTHER

Arm 1: Cognitive-dissonance based program

The first four sessions focus on body image and the last four sessions on eating behavior.

OTHER

Arm 2: Mindfulness-based program

The sessions focus on different contents as body image, eating behavior and emotion regulation.

OTHER

Arm 3: Person-centered program

The sessions are not structured. Participants can bring any subject they need to talk.

Sponsors & Collaborators

  • Université Lumière Lyon 2

    lead OTHER

Principal Investigators

  • Roxane Turgon · Université Lumière Lyon 2

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-01-29
Completion
2022-09-22

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05140109 on ClinicalTrials.gov